Table IV.
Treatment results.
| Objective response, n (%) | QoL, n (%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Groups | Total cases, n | CR | PR | NC | PD | ORR | Better | NC | Worse | KPS IR, % |
| Study | 130 | 49 (37.7) | 52 (40.0) | 29 (22.3) | 0 (0.0) | 101 (77.7) | 64 (49.2) | 53 (40.8) | 13 (10.0) | 49.2 |
| Control | 130 | 35 (26.9) | 48 (36.9) | 47 (36.2) | 0 (0.0) | 83 (63.8) | 42 (32.3) | 68 (52.3) | 20 (15.4) | 32.3 |
| P-value | <0.05 | <0.05 | ||||||||
CR, complete response; PR, partial response; NC, no change; PD, progressive disease; ORR, objective response rate; QoL, quality of life; KPS IR, Karnofsky performance score improvement rate.